What does it take to provide cancer patients with comprehensive medication therapy management services for oral chemotherapy?

Ivo L Abraham, Luis Canais, Marti Larriva, Ali McBride, Reem Diri, Karen MacDonald

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1-3
Number of pages3
JournalExpert Opinion on Drug Safety
DOIs
StateAccepted/In press - Mar 17 2016

Fingerprint

Medication Therapy Management
Antineoplastic Agents
Oral Administration
Drug Therapy
Neoplasms

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

What does it take to provide cancer patients with comprehensive medication therapy management services for oral chemotherapy? / Abraham, Ivo L; Canais, Luis; Larriva, Marti; McBride, Ali; Diri, Reem; MacDonald, Karen.

In: Expert Opinion on Drug Safety, 17.03.2016, p. 1-3.

Research output: Contribution to journalArticle

@article{34c61650f3ff45f692933c650ff082f8,
title = "What does it take to provide cancer patients with comprehensive medication therapy management services for oral chemotherapy?",
author = "Abraham, {Ivo L} and Luis Canais and Marti Larriva and Ali McBride and Reem Diri and Karen MacDonald",
year = "2016",
month = "3",
day = "17",
doi = "10.1517/14740338.2016.1158249",
language = "English (US)",
pages = "1--3",
journal = "Expert Opinion on Drug Safety",
issn = "1474-0338",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - What does it take to provide cancer patients with comprehensive medication therapy management services for oral chemotherapy?

AU - Abraham, Ivo L

AU - Canais, Luis

AU - Larriva, Marti

AU - McBride, Ali

AU - Diri, Reem

AU - MacDonald, Karen

PY - 2016/3/17

Y1 - 2016/3/17

UR - http://www.scopus.com/inward/record.url?scp=84961205628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961205628&partnerID=8YFLogxK

U2 - 10.1517/14740338.2016.1158249

DO - 10.1517/14740338.2016.1158249

M3 - Article

C2 - 26905259

AN - SCOPUS:84961205628

SP - 1

EP - 3

JO - Expert Opinion on Drug Safety

JF - Expert Opinion on Drug Safety

SN - 1474-0338

ER -